Items where Author is "Briggs, Andrew"

Number of items: 98.
Article
  • Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective. (2021) Alsumali, Adnan; Djatche, Laurence M; Briggs, Andrew; Liu, Rongzhe; Diakite, Ibrahim; Patel, Dipen; Wang, Yufei; Lautsch, Dominik
  • 'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies. (2018) Annemans, Lieven; Packard, Chris J; Briggs, Andrew; Ray, Kausik K
  • Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic. (2021) Asukai, Yumi; Briggs, Andrew; Garrison, Louis P; Geisler, Benjamin P; Neumann, Peter J; Ollendorf, Daniel A
  • Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial. (2020) Bhatt, Deepak L; Briggs, Andrew H; Reed, Shelby D; Annemans, Lieven; Szarek, Michael; Bittner, Vera A; Diaz, Rafael; Goodman, Shaun G; Harrington, Robert A; Higuchi, Keiko; Joulain, Florence; Jukema, J Wouter; Li, Qian H; Mahaffey, Kenneth W; Sanchez, Robert J; Roe, Matthew T; Lopes, Renato D; White, Harvey D; Zeiher, Andreas M; Schwartz, Gregory G; Gabriel Steg, Ph; ODYSSEY OUTCOMES Investigators
  • Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study. (2022) Bidulka, Patrick; Mathur, Rohini; Lugo-Palacios, David G; O'Neill, Stephen; Basu, Anirban; Silverwood, Richard J; Charlton, Paul; Briggs, Andrew; Smeeth, Liam; Adler, Amanda I; Douglas, Ian J; Khunti, Kamlesh; Grieve, Richard
  • Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study. (2021) Bidulka, Patrick; O'Neill, Stephen; Basu, Anirban; Wilkinson, Samantha; Silverwood, Richard J; Charlton, Paul; Briggs, Andrew; Adler, Amanda I; Khunti, Kamlesh; Tomlinson, Laurie A; Smeeth, Liam; Douglas, Ian J; Grieve, Richard
  • Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). (2017) Bousquet, J; Farrell, J; Crooks, G; Hellings, P; Bel, EH; Bewick, M; Chavannes, NH; de Sousa, J Correia; Cruz, AA; Haahtela, T; Joos, G; Khaltaev, N; Malva, J; Muraro, A; Nogues, M; Palkonen, S; Pedersen, S; Robalo-Cordeiro, C; Samolinski, B; Strandberg, T; Valiulis, A; Yorgancioglu, A; Zuberbier, T; Bedbrook, A; Aberer, W; Adachi, M; Agusti, A; Akdis, CA; Akdis, M; Ankri, J; Alonso, A; Annesi-Maesano, I; Ansotegui, IJ; Anto, JM; Arnavielhe, S; Arshad, H; Bai, C; Baiardini, I; Bachert, C; Baigenzhin, AK; Barbara, C; Bateman, ED; Beghé, B; Kheder, A Ben; Bennoor, KS; Benson, M; Bergmann, KC; Bieber, T; Bindslev-Jensen, C; Bjermer, L; Blain, H; Blasi, F; Boner, AL; Bonini, M; Bonini, S; Bosnic-Anticevitch, S; Boulet, LP; Bourret, R; Bousquet, PJ; Braido, F; Briggs, AH; Brightling, CE; Brozek, J; Buhl, R; Burney, PG; Bush, A; Caballero-Fonseca, F; Caimmi, D; Calderon, MA; Calverley, PM; Camargos, PAM; Canonica, GW; Camuzat, T; Carlsen, KH; Carr, W; Carriazo, A; Casale, T; Cepeda Sarabia, AM; Chatzi, L; Chen, YZ; Chiron, R; Chkhartishvili, E; Chuchalin, AG; Chung, KF; Ciprandi, G; Cirule, I; Cox, L; Costa, DJ; Custovic, A; Dahl, R; Dahlen, SE; Darsow, U; De Carlo, G; De Blay, F; Dedeu, T; Deleanu, D; De Manuel Keenoy, E; Demoly, P; Denburg, JA; Devillier, P; Didier, A; Dinh-Xuan, AT; Djukanovic, R; Dokic, D; Douagui, H; Dray, G; Dubakiene, R; Durham, SR; Dykewicz, MS; El-Gamal, Y; Emuzyte, R; Fabbri, LM; Fletcher, M; Fiocchi, A; Fink Wagner, A; Fonseca, J; Fokkens, WJ; Forastiere, F; Frith, P; Gaga, M; Gamkrelidze, A; Garces, J; Garcia-Aymerich, J; Gemicioğlu, B; Gereda, JE; González Diaz, S; Gotua, M; Grisle, I; Grouse, L; Gutter, Z; Guzmán, MA; Heaney, LG; Hellquist-Dahl, B; Henderson, D; Hendry, A; Heinrich, J; Heve, D; Horak, F; Hourihane, J O' B; Howarth, P; Humbert, M; Hyland, ME; Illario, M; Ivancevich, JC; Jardim, JR; Jares, EJ; Jeandel, C; Jenkins, C; Johnston, SL; Jonquet, O; Julge, K; Jung, KS; Just, J; Kaidashev, I; Khaitov, MR; Kalayci, O; Kalyoncu, AF; Keil, T; Keith, PK; Klimek, L; Koffi N'Goran, B; Kolek, V; Koppelman, GH; Kowalski, ML; Kull, I; Kuna, P; Kvedariene, V; Lambrecht, B; Lau, S; Larenas-Linnemann, D; Laune, D; Le, LTT; Lieberman, P; Lipworth, B; Li, J; Lodrup Carlsen, K; Louis, R; MacNee, W; Magard, Y; Magnan, A; Mahboub, B; Mair, A; Majer, I; Makela, MJ; Manning, P; Mara, S; Marshall, GD; Masjedi, MR; Matignon, P; Maurer, M; Mavale-Manuel, S; Melén, E; Melo-Gomes, E; Meltzer, EO; Menzies-Gow, A; Merk, H; Michel, JP; Miculinic, N; Mihaltan, F; Milenkovic, B; Mohammad, GMY; Molimard, M; Momas, I; Montilla-Santana, A; Morais-Almeida, M; Morgan, M; Mösges, R; Mullol, J; Nafti, S; Namazova-Baranova, L; Naclerio, R; Neou, A; Neffen, H; Nekam, K; Niggemann, B; Ninot, G; Nyembue, TD; O'Hehir, RE; Ohta, K; Okamoto, Y; Okubo, K; Ouedraogo, S; Paggiaro, P; Pali-Schöll, I; Panzner, P; Papadopoulos, N; Papi, A; Park, HS; Passalacqua, G; Pavord, I; Pawankar, R; Pengelly, R; Pfaar, O; Picard, R; Pigearias, B; Pin, I; Plavec, D; Poethig, D; Pohl, W; Popov, TA; Portejoie, F; Potter, P; Postma, D; Price, D; Rabe, KF; Raciborski, F; Radier Pontal, F; Repka-Ramirez, S; Reitamo, S; Rennard, S; Rodenas, F; Roberts, J; Roca, J; Rodriguez Mañas, L; Rolland, C; Roman Rodriguez, M; Romano, A; Rosado-Pinto, J; Rosario, N; Rosenwasser, L; Rottem, M; Ryan, D; Sanchez-Borges, M; Scadding, GK; Schunemann, HJ; Serrano, E; Schmid-Grendelmeier, P; Schulz, H; Sheikh, A; Shields, M; Siafakas, N; Sibille, Y; Similowski, T; Simons, FER; Sisul, JC; Skrindo, I; Smit, HA; Solé, D; Sooronbaev, T; Spranger, O; Stelmach, R; Sterk, PJ; Sunyer, J; Thijs, C; To, T; Todo-Bom, A; Triggiani, M; Valenta, R; Valero, AL; Valia, E; Valovirta, E; Van Ganse, E; van Hage, M; Vandenplas, O; Vasankari, T; Vellas, B; Vestbo, J; Vezzani, G; Vichyanond, P; Viegi, G; Vogelmeier, C; Vontetsianos, T; Wagenmann, M; Wallaert, B; Walker, S; Wang, DY; Wahn, U; Wickman, M; Williams, DM; Williams, S; Wright, J; Yawn, BP; Yiallouros, PK; Yusuf, OM; Zaidi, A; Zar, HJ; Zernotti, ME; Zhang, L; Zhong, N; Zidarn, M; Mercier, J
  • Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). (2016) Bousquet, J; Farrell, J; Crooks, G; Hellings, P; Bel, EH; Bewick, M; Chavannes, NH; de Sousa, J Correia; Cruz, AA; Haahtela, T; Joos, G; Khaltaev, N; Malva, J; Muraro, A; Nogues, M; Palkonen, S; Pedersen, S; Robalo-Cordeiro, C; Samolinski, B; Strandberg, T; Valiulis, A; Yorgancioglu, A; Zuberbier, T; Bedbrook, A; Aberer, W; Adachi, M; Agusti, A; Akdis, CA; Akdis, M; Ankri, J; Alonso, A; Annesi-Maesano, I; Ansotegui, IJ; Anto, JM; Arnavielhe, S; Arshad, H; Bai, C; Baiardini, I; Bachert, C; Baigenzhin, AK; Barbara, C; Bateman, ED; Beghé, B; Kheder, A Ben; Bennoor, KS; Benson, M; Bergmann, KC; Bieber, T; Bindslev-Jensen, C; Bjermer, L; Blain, H; Blasi, F; Boner, AL; Bonini, M; Bonini, S; Bosnic-Anticevitch, S; Boulet, LP; Bourret, R; Bousquet, PJ; Braido, F; Briggs, AH; Brightling, CE; Brozek, J; Buhl, R; Burney, PG; Bush, A; Caballero-Fonseca, F; Caimmi, D; Calderon, MA; Calverley, PM; Camargos, PAM; Canonica, GW; Camuzat, T; Carlsen, KH; Carr, W; Carriazo, A; Casale, T; Cepeda Sarabia, AM; Chatzi, L; Chen, YZ; Chiron, R; Chkhartishvili, E; Chuchalin, AG; Chung, KF; Ciprandi, G; Cirule, I; Cox, L; Costa, DJ; Custovic, A; Dahl, R; Dahlen, SE; Darsow, U; De Carlo, G; De Blay, F; Dedeu, T; Deleanu, D; De Manuel Keenoy, E; Demoly, P; Denburg, JA; Devillier, P; Didier, A; Dinh-Xuan, AT; Djukanovic, R; Dokic, D; Douagui, H; Dray, G; Dubakiene, R; Durham, SR; Dykewicz, MS; El-Gamal, Y; Emuzyte, R; Fabbri, LM; Fletcher, M; Fiocchi, A; Fink Wagner, A; Fonseca, J; Fokkens, WJ; Forastiere, F; Frith, P; Gaga, M; Gamkrelidze, A; Garces, J; Garcia-Aymerich, J; Gemicioğlu, B; Gereda, JE; González Diaz, S; Gotua, M; Grisle, I; Grouse, L; Gutter, Z; Guzmán, MA; Heaney, LG; Hellquist-Dahl, B; Henderson, D; Hendry, A; Heinrich, J; Heve, D; Horak, F; Hourihane, J O' B; Howarth, P; Humbert, M; Hyland, ME; Illario, M; Ivancevich, JC; Jardim, JR; Jares, EJ; Jeandel, C; Jenkins, C; Johnston, SL; Jonquet, O; Julge, K; Jung, KS; Just, J; Kaidashev, I; Kaitov, MR; Kalayci, O; Kalyoncu, AF; Keil, T; Keith, PK; Klimek, L; Koffi N'Goran, B; Kolek, V; Koppelman, GH; Kowalski, ML; Kull, I; Kuna, P; Kvedariene, V; Lambrecht, B; Lau, S; Larenas-Linnemann, D; Laune, D; Le, LTT; Lieberman, P; Lipworth, B; Li, J; Lodrup Carlsen, K; Louis, R; MacNee, W; Magard, Y; Magnan, A; Mahboub, B; Mair, A; Majer, I; Makela, MJ; Manning, P; Mara, S; Marshall, GD; Masjedi, MR; Matignon, P; Maurer, M; Mavale-Manuel, S; Melén, E; Melo-Gomes, E; Meltzer, EO; Menzies-Gow, A; Merk, H; Michel, JP; Miculinic, N; Mihaltan, F; Milenkovic, B; Mohammad, GMY; Molimard, M; Momas, I; Montilla-Santana, A; Morais-Almeida, M; Morgan, M; Mösges, R; Mullol, J; Nafti, S; Namazova-Baranova, L; Naclerio, R; Neou, A; Neffen, H; Nekam, K; Niggemann, B; Ninot, G; Nyembue, TD; O'Hehir, RE; Ohta, K; Okamoto, Y; Okubo, K; Ouedraogo, S; Paggiaro, P; Pali-Schöll, I; Panzner, P; Papadopoulos, N; Papi, A; Park, HS; Passalacqua, G; Pavord, I; Pawankar, R; Pengelly, R; Pfaar, O; Picard, R; Pigearias, B; Pin, I; Plavec, D; Poethig, D; Pohl, W; Popov, TA; Portejoie, F; Potter, P; Postma, D; Price, D; Rabe, KF; Raciborski, F; Radier Pontal, F; Repka-Ramirez, S; Reitamo, S; Rennard, S; Rodenas, F; Roberts, J; Roca, J; Rodriguez Mañas, L; Rolland, C; Roman Rodriguez, M; Romano, A; Rosado-Pinto, J; Rosario, N; Rosenwasser, L; Rottem, M; Ryan, D; Sanchez-Borges, M; Scadding, GK; Schunemann, HJ; Serrano, E; Schmid-Grendelmeier, P; Schulz, H; Sheikh, A; Shields, M; Siafakas, N; Sibille, Y; Similowski, T; Simons, FER; Sisul, JC; Skrindo, I; Smit, HA; Solé, D; Sooronbaev, T; Spranger, O; Stelmach, R; Sterk, PJ; Sunyer, J; Thijs, C; To, T; Todo-Bom, A; Triggiani, M; Valenta, R; Valero, AL; Valia, E; Valovirta, E; Van Ganse, E; van Hage, M; Vandenplas, O; Vasankari, T; Vellas, B; Vestbo, J; Vezzani, G; Vichyanond, P; Viegi, G; Vogelmeier, C; Vontetsianos, T; Wagenmann, M; Wallaert, B; Walker, S; Wang, DY; Wahn, U; Wickman, M; Williams, DM; Williams, S; Wright, J; Yawn, BP; Yiallouros, PK; Yusuf, OM; Zaidi, A; Zar, HJ; Zernotti, ME; Zhang, L; Zhong, N; Zidarn, M; Mercier, J
  • ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. (2016) Bousquet, J; Hellings, PW; Agache, I; Bedbrook, A; Bachert, C; Bergmann, KC; Bewick, M; Bindslev-Jensen, C; Bosnic-Anticevitch, S; Bucca, C; Caimmi, DP; Camargos, PAM; Canonica, GW; Casale, T; Chavannes, NH; Cruz, AA; De Carlo, G; Dahl, R; Demoly, P; Devillier, P; Fonseca, J; Fokkens, WJ; Guldemond, NA; Haahtela, T; Illario, M; Just, J; Keil, T; Klimek, L; Kuna, P; Larenas-Linnemann, D; Morais-Almeida, M; Mullol, J; Murray, R; Naclerio, R; O'Hehir, RE; Papadopoulos, NG; Pawankar, R; Potter, P; Ryan, D; Samolinski, B; Schunemann, HJ; Sheikh, A; Simons, FER; Stellato, C; Todo-Bom, A; Tomazic, PV; Valiulis, A; Valovirta, E; Ventura, MT; Wickman, M; Young, I; Yorgancioglu, A; Zuberbier, T; Aberer, W; Akdis, CA; Akdis, M; Annesi-Maesano, I; Ankri, J; Ansotegui, IJ; Anto, JM; Arnavielhe, S; Asarnoj, A; Arshad, H; Avolio, F; Baiardini, I; Barbara, C; Barbagallo, M; Bateman, ED; Beghé, B; Bel, EH; Bennoor, KS; Benson, M; Białoszewski, AZ; Bieber, T; Bjermer, L; Blain, H; Blasi, F; Boner, AL; Bonini, M; Bonini, S; Bosse, I; Bouchard, J; Boulet, LP; Bourret, R; Bousquet, PJ; Braido, F; Briggs, AH; Brightling, CE; Brozek, J; Buhl, R; Bunu, C; Burte, E; Bush, A; Caballero-Fonseca, F; Calderon, MA; Camuzat, T; Cardona, V; Carreiro-Martins, P; Carriazo, AM; Carlsen, KH; Carr, W; Cepeda Sarabia, AM; Cesari, M; Chatzi, L; Chiron, R; Chivato, T; Chkhartishvili, E; Chuchalin, AG; Chung, KF; Ciprandi, G; de Sousa, J Correia; Cox, L; Crooks, G; Custovic, A; Dahlen, SE; Darsow, U; Dedeu, T; Deleanu, D; Denburg, JA; De Vries, G; Didier, A; Dinh-Xuan, AT; Dokic, D; Douagui, H; Dray, G; Dubakiene, R; Durham, SR; Du Toit, G; Dykewicz, MS; Eklund, P; El-Gamal, Y; Ellers, E; Emuzyte, R; Farrell, J; Fink Wagner, A; Fiocchi, A; Fletcher, M; Forastiere, F; Gaga, M; Gamkrelidze, A; Gemicioğlu, B; Gereda, JE; van Wick, R Gerth; González Diaz, S; Grisle, I; Grouse, L; Gutter, Z; Guzmán, MA; Hellquist-Dahl, B; Heinrich, J; Horak, F; Hourihane, J O' B; Humbert, M; Hyland, M; Iaccarino, G; Jares, EJ; Jeandel, C; Johnston, SL; Joos, G; Jonquet, O; Jung, KS; Jutel, M; Kaidashev, I; Khaitov, M; Kalayci, O; Kalyoncu, AF; Kardas, P; Keith, PK; Kerkhof, M; Kerstjens, HAM; Khaltaev, N; Kogevinas, M; Kolek, V; Koppelman, GH; Kowalski, ML; Kuitunen, M; Kull, I; Kvedariene, V; Lambrecht, B; Lau, S; Laune, D; Le, LTT; Lieberman, P; Lipworth, B; Li, J; Lodrup Carlsen, KC; Louis, R; Lupinek, C; MacNee, W; Magar, Y; Magnan, A; Mahboub, B; Maier, D; Majer, I; Malva, J; Manning, P; De Manuel Keenoy, E; Marshall, GD; Masjedi, MR; Mathieu-Dupas, E; Maurer, M; Mavale-Manuel, S; Melén, E; Melo-Gomes, E; Meltzer, EO; Mercier, J; Merk, H; Miculinic, N; Mihaltan, F; Milenkovic, B; Millot-Keurinck, J; Mohammad, Y; Momas, I; Mösges, R; Muraro, A; Namazova-Baranova, L; Nadif, R; Neffen, H; Nekam, K; Nieto, A; Niggemann, B; Nogueira-Silva, L; Nogues, M; Nyembue, TD; Ohta, K; Okamoto, Y; Okubo, K; Olive-Elias, M; Ouedraogo, S; Paggiaro, P; Pali-Schöll, I; Palkonen, S; Panzner, P; Papi, A; Park, HS; Passalacqua, G; Pedersen, S; Pereira, AM; Pfaar, O; Picard, R; Pigearias, B; Pin, I; Plavec, D; Pohl, W; Popov, TA; Portejoie, F; Postma, D; Poulsen, LK; Price, D; Rabe, KF; Raciborski, F; Roberts, G; Robalo-Cordeiro, C; Rodenas, F; Rodriguez-Mañas, L; Rolland, C; Roman Rodriguez, M; Romano, A; Rosado-Pinto, J; Rosario, N; Rottem, M; Sanchez-Borges, M; Sastre-Dominguez, J; Scadding, GK; Scichilone, N; Schmid-Grendelmeier, P; Serrano, E; Shields, M; Siroux, V; Sisul, JC; Skrindo, I; Smit, HA; Solé, D; Sooronbaev, T; Spranger, O; Stelmach, R; Sterk, PJ; Strandberg, T; Sunyer, J; Thijs, C; Triggiani, M; Valenta, R; Valero, A; van Eerd, M; van Ganse, E; van Hague, M; Vandenplas, O; Varona, LL; Vellas, B; Vezzani, G; Vazankari, T; Viegi, G; Vontetsianos, T; Wagenmann, M; Walker, S; Wang, DY; Wahn, U; Werfel, T; Whalley, B; Williams, DM; Williams, S; Wilson, N; Wright, J; Yawn, BP; Yiallouros, PK; Yusuf, OM; Zaidi, A; Zar, HJ; Zernotti, ME; Zhang, L; Zhong, N; Zidarn, M
  • The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011. (2016) Bouttell, Janet; Lewsey, James; Geue, Claudia; Antony, Grace; Briggs, Andrew; McCartney, Gerry; Hutchinson, Sharon; Graham, Lesley; Heydtmann, Mathis
  • Healing the past, reimagining the present, investing in the future: What should be the role of race as a proxy covariate in health economics informed health care policy? (2022) Briggs, Andrew H
  • Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease. (2019) Briggs, Andrew H; Belozeroff, Vasily; Feeny, David
  • Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trial. (2017) Briggs, Andrew H; Bhatt, Deepak L; Scirica, Benjamin M; Raz, Itamar; Johnston, Karissa M; Szabo, Shelagh M; Bergenheim, Klas; Mukherjee, Jayanti; Hirshberg, Boaz; Mosenzon, Ofri
  • Missing... presumed at random: cost-analysis of incomplete data. (2003) Briggs, Andrew; Clark, Taane; Wolstenholme, Jane; Clarke, Philip
  • Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma. (2020) Briggs, Andrew; Daniele, Bruno; Dick, Katherine; Evans, Thomas R Jeffry; Galle, Peter R; Hubner, Richard A; Lopez, Carlos; Siebert, Uwe; Tremblay, Gabriel
  • Challenges for decision-makers when assessing within-class comparative effectiveness: the case of anticoagulation therapy for atrial fibrillation. (2022) Briggs, Andrew; Howarth, Amanda; Davies, Shawn; Schneider, John; Spentzouris, Georgios; Mughal, Farhan; Fuat, Ahmet; Fay, Matthew
  • The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data. (2021) Briggs, Andrew; Nasser, Shuaib; Hammerby, Eva; Buchs, Sarah; Virchow, J Christian
  • Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study. (2021) Briggs, Andrew; Paracha, Noman; Rosettie, Katherine; Upton, Alexander; Bokemeyer, Carsten; Lassen, Ulrik; Sullivan, Sean D
  • Count the cost of disability caused by COVID-19. (2021) Briggs, Andrew; Vassall, Anna
  • PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform. (2017) Claes, Jomme; Buys, Roselien; Woods, Catherine; Briggs, Andrew; Geue, Claudia; Aitken, Moira; Moyna, Niall; Moran, Kieran; McCaffrey, Noel; Chouvarda, Ioanna; Walsh, Deirdre; Budts, Werner; Filos, Dimitris; Triantafyllidis, Andreas; Maglaveras, Nicos; Cornelissen, Véronique A
  • The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). (2003) Clarke, P; Gray, A; Legood, R; Briggs, A; Holman, R
  • Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review. (2020) Cooper, Jacie T; Lloyd, Andrew; Sanchez, Juan Jose Garcia; Sörstadius, Elisabeth; Briggs, Andrew; McFarlane, Phil
  • Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS). (2022) Cotton, Seonaidh; Devereux, Graham; Abbas, Hassan; Briggs, Andrew; Campbell, Karen; Chaudhuri, Rekha; Choudhury, Gourab; Dawson, Dana; De Soyza, Anthony; Fielding, Shona; Gompertz, Simon; Haughney, John; Lang, Chim C; Lee, Amanda J; MacLennan, Graeme; MacNee, William; McCormack, Kirsty; McMeekin, Nicola; Mills, Nicholas L; Morice, Alyn; Norrie, John; Petrie, Mark C; Price, David; Short, Philip; Vestbo, Jorgen; Walker, Paul; Wedzicha, Jadwiga; Wilson, Andrew; Lipworth, Brian J
  • How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines? (2022) Cowie, Martin R; Bozkurt, Biykem; Butler, Javed; Briggs, Andrew; Kubin, Maria; Jonas, Adrian; Adler, Amanda I; Patrick-Lake, Bray; Zannad, Faiez
  • Modifying Alcohol Consumption to Reduce Obesity (MACRO): development and feasibility trial of a complex community-based intervention for men. (2017) Crombie, Iain K; Cunningham, Kathryn B; Irvine, Linda; Williams, Brian; Sniehotta, Falko F; Norrie, John; Melson, Ambrose; Jones, Claire; Briggs, Andrew; Rice, Peter M; Achison, Marcus; McKenzie, Andrew; Dimova, Elena; Slane, Peter W
  • Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data. (2020) Dakin, Helen A; Leal, José; Briggs, Andrew; Clarke, Philip; Holman, Rury R; Gray, Alastair
  • Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. (2019) Devereux, Graham; Cotton, Seonaidh; Fielding, Shona; McMeekin, Nicola; Barnes, Peter J; Briggs, Andy; Burns, Graham; Chaudhuri, Rekha; Chrystyn, Henry; Davies, Lisa; Soyza, Anthony De; Gompertz, Simon; Haughney, John; Innes, Karen; Kaniewska, Joanna; Lee, Amanda; Morice, Alyn; Norrie, John; Sullivan, Anita; Wilson, Andrew; Price, David
  • Application of a Mapping Function to Estimate Utilities for Ragweed Allergy Immunotherapy Trials. (2020) Dick, Katherine; Briggs, Andrew; Brandi, Henrik
  • A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial. (2019) Dick, Katherine; Briggs, Andrew; Ohsfeldt, Robert; Sydendal Grand, Tobias; Buchs, Sarah
  • Mendelian randomization: estimation of inpatient hospital costs attributable to obesity. (2021) Dick, Katherine; Schneider, John E; Briggs, Andrew; Lecomte, Pascal; Regnier, Stephane A; Lean, Michael
  • Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial. (2018) Ford, Thomas J; Corcoran, David; Oldroyd, Keith G; McEntegart, Margaret; Rocchiccioli, Paul; Watkins, Stuart; Brooksbank, Katriona; Padmanabhan, Sandosh; Sattar, Naveed; Briggs, Andrew; McConnachie, Alex; Touyz, Rhian; Berry, Colin
  • Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US. (2022) Goswami, Hardik; Alsumali, Adnan; Jiang, Yiling; Schindler, Matthias; Duke, Elizabeth R; Cohen, Joshua; Briggs, Andrew; Puenpatom, Amy
  • Long-term weight loss trajectories following participation in a randomised controlled trial of a weight management programme for men delivered through professional football clubs: a longitudinal cohort study and economic evaluation. (2018) Gray, Cindy M; Wyke, Sally; Zhang, Ruiqi; Anderson, Annie S; Barry, Sarah; Boyer, Nicki; Brennan, Graham; Briggs, Andrew; Bunn, Christopher; Donnachie, Craig; Grieve, Eleanor; Kohli-Lynch, Ciaran; Lloyd, Suzanne M; McConnachie, Alex; McCowan, Colin; MacLean, Alice; Mutrie, Nanette; Hunt, Kate
  • The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia. (2022) Gumley, Andrew I; Bradstreet, Simon; Ainsworth, John; Allan, Stephanie; Alvarez-Jimenez, Mario; Aucott, Lorna; Birchwood, Maximillian; Briggs, Andrew; Bucci, Sandra; Cotton, Sue M; Engel, Lidia; French, Paul; Lederman, Reeva; Lewis, Shôn; Machin, Matthew; MacLennan, Graeme; McLeod, Hamish; McMeekin, Nicola; Mihalopoulos, Cathy; Morton, Emma; Norrie, John; Schwannauer, Matthias; Singh, Swaran P; Sundram, Suresh; Thompson, Andrew; Williams, Chris; Yung, Alison R; Farhall, John; Gleeson, John
  • Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT. (2022) Gumley, Andrew I; Bradstreet, Simon; Ainsworth, John; Allan, Stephanie; Alvarez-Jimenez, Mario; Birchwood, Maximillian; Briggs, Andrew; Bucci, Sandra; Cotton, Sue; Engel, Lidia; French, Paul; Lederman, Reeva; Lewis, Shôn; Machin, Matthew; MacLennan, Graeme; McLeod, Hamish; McMeekin, Nicola; Mihalopoulos, Cathy; Morton, Emma; Norrie, John; Reilly, Frank; Schwannauer, Matthias; Singh, Swaran P; Sundram, Suresh; Thompson, Andrew; Williams, Chris; Yung, Alison; Aucott, Lorna; Farhall, John; Gleeson, John
  • Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer Support. (2020) Gumley, Andrew; Bradstreet, Simon; Ainsworth, John; Allan, Stephanie; Alvarez-Jimenez, Mario; Beattie, Louise; Bell, Imogen; Birchwood, Max; Briggs, Andrew; Bucci, Sandra; Castagnini, Emily; Clark, Andrea; Cotton, Sue M; Engel, Lidia; French, Paul; Lederman, Reeva; Lewis, Shon; Machin, Matthew; MacLennan, Graeme; Matrunola, Claire; McLeod, Hamish; McMeekin, Nicola; Mihalopoulos, Cathrine; Morton, Emma; Norrie, John; Reilly, Frank; Schwannauer, Matthias; Singh, Swaran P; Smith, Lesley; Sundram, Suresh; Thomson, David; Thompson, Andrew; Whitehill, Helen; Wilson-Kay, Alison; Williams, Christopher; Yung, Alison; Farhall, John; Gleeson, John
  • Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis. (2021) Hanna, Catherine R; Robles-Zurita, Jose A; Briggs, Andrew; Harkin, Andrea; Kelly, Caroline; McQueen, John; Allan, Karen; Pearson, Sarah; Hollander, Henrik; Glimelius, Bengt; Salazar, Ramon; Segelov, Eva; Saunders, Mark; Iveson, Tim; Jones, Robert J; Boyd, Kathleen A
  • Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models. (2018) Hatswell, Anthony J; Bullement, Ash; Briggs, Andrew; Paulden, Mike; Stevenson, Matthew D
  • Stratified medicine using invasive coronary function testing in angina: A cost-effectiveness analysis of the British Heart Foundation CorMicA trial. (2021) Heggie, R; Briggs, A; Stanley, B; Good, R; Rocchiccioli, P; McEntegart, M; Watkins, S; Eteiba, H; Shaukat, A; Lindsay, M; Robertson, K; Hood, S; McGeoch, R; McDade, R; Yii, E; Collison, D; Oldroyd, K; Ford, TJ; Berry, C
  • Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. (2013) Hemingway, Harry; Croft, Peter; Perel, Pablo; Hayden, Jill A; Abrams, Keith; Timmis, Adam; Briggs, Andrew; Udumyan, Ruzan; Moons, Karel GM; Steyerberg, Ewout W; Roberts, Ian; Schroter, Sara; Altman, Douglas G; Riley, Richard D; PROGRESS Group
  • Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT). (2023) Herrett, Emily; Tomlin, Keith; Lin, Liang-Yu; Tomlinson, Laurie A; Jit, Mark; Briggs, Andrew; Marks, Michael; Sandmann, Frank; Parry, John; Bates, Christopher; Morley, Jessica; Bacon, Seb; Butler-Cole, Benjamin; Mahalingasivam, Viyaasan; Dennison, Alan; Smith, Deb; Gabriel, Ethan; Mehrkar, Amir; Goldacre, Ben; Smeeth, Liam; Eggo, Rosalind MM
  • Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. (2017) Hoogendoorn, Martine; Feenstra, Talitha L; Boland, Melinde; Briggs, Andrew H; Borg, Sixten; Jansson, Sven-Arne; Risebrough, Nancy A; Slejko, Julia F; Rutten-van Mölken, Maureen Pmh
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. (2022) Husereau, D; Drummond, M; Augustovski, F; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; de Bekker-Grob, E; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, R-F; Staniszewska, S; CHEERS 2022 ISPOR Good Research Practices Task Force
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Daniel Mullins, C; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie
  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie; CHEERS 2022 ISPOR Good Research Practices Task Force
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie; CHEERS 2022 ISPOR Good Research Practices Task Force
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie; CHEERS 2022 ISPOR Good Research Practices Task Force
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie; CHEERS 2022 ISPOR Good Research Practices Task Force
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie; CHEERS 2022 ISPOR Good Research Practices Task Force
  • Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie; CHEERS 2022 ISPOR Good Research Practices Task Force
  • Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. (2022) Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie; CHEERS 2022 ISPOR Good Research Practices Task Force
  • Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review. (2020) Hájek, Roman; Gonzalez-McQuire, Sebastian; Szabo, Zsolt; Delforge, Michel; DeCosta, Lucy; Raab, Marc S; Bouwmeester, Walter; Campioni, Marco; Briggs, Andrew
  • Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis. (2020) Italiano, Antoine; Nanda, Shivani; Briggs, Andrew; Garcia-Foncillas, Jesus; Lassen, Ulrik; Vassal, Gilles; Kummar, Shivaani; van Tilburg, Cornelis M; Hong, David S; Laetsch, Theodore W; Keating, Karen; Reeves, John A; Fellous, Marc; Childs, Barrett H; Drilon, Alexander; Hyman, David M
  • 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. (2018) Iveson, Timothy J; Kerr, Rachel S; Saunders, Mark P; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Scudder, Claire; Boyd, Kathleen Anne; Briggs, Andrew; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S; Harrison, Mark; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet S; Paul, James
  • 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. (2019) Iveson, Timothy; Boyd, Kathleen A; Kerr, Rachel S; Robles-Zurita, Jose; Saunders, Mark P; Briggs, Andrew H; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S; Harrison, Mark; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet; Paul, James
  • Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial. (2017) Jahoda, Andrew; Hastings, Richard; Hatton, Chris; Cooper, Sally-Ann; Dagnan, Dave; Zhang, Ruiqi; McConnachie, Alex; McMeekin, Nicola; Appleton, Kim; Jones, Rob; Scott, Katie; Fulton, Lauren; Knight, Rosie; Knowles, Dawn; Williams, Chris; Briggs, Andrew; MacMahon, Ken; Lynn, Helen; Smith, Ian; Thomas, Gail; Melville, Craig
  • The feasibility of a randomised controlled trial to compare the cost-effectiveness of palliative cardiology or usual care in people with advanced heart failure: Two exploratory prospective cohorts. (2018) Johnson, Miriam J; McSkimming, Paula; McConnachie, Alex; Geue, Claudia; Millerick, Yvonne; Briggs, Andrew; Hogg, Karen
  • The ankle injury management (AIM) trial: A pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years. (2016) Keene, DJ; Mistry, D; Nam, J; Tutton, E; Handley, R; Morgan, L; Roberts, E; Gray, B; Briggs, A; Lall, R; Chesser, TJS; Pallister, I; Lamb, SE; Willett, K
  • The Ankle Injury Management (AIM) trial: a pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years. (2016) Keene, David J; Mistry, Dipesh; Nam, Julian; Tutton, Elizabeth; Handley, Robert; Morgan, Lesley; Roberts, Emma; Gray, Bridget; Briggs, Andrew; Lall, Ranjit; Chesser, Tim Js; Pallister, Ian; Lamb, Sarah E; Willett, Keith
  • Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. (2022) Kohli-Lynch, Ciaran N; Lewsey, James; Boyd, Kathleen A; French, Dustin D; Jordan, Neil; Moran, Andrew E; Sattar, Naveed; Preiss, David; Briggs, Andrew H
  • A cardiovascular disease policy model: part 2-preparing for economic evaluation and to assess health inequalities. (2016) Lawson, KD; Lewsey, JD; Ford, I; Fox, K; Ritchie, LD; Tunstall-Pedoe, H; Watt, GCM; Woodward, M; Kent, S; Neilson, M; Briggs, AH
  • Oral versus Intravenous Antibiotics for Bone and Joint Infection. (2019) Li, Ho-Kwong; Rombach, Ines; Zambellas, Rhea; Walker, A Sarah; McNally, Martin A; Atkins, Bridget L; Lipsky, Benjamin A; Hughes, Harriet C; Bose, Deepa; Kümin, Michelle; Scarborough, Claire; Matthews, Philippa C; Brent, Andrew J; Lomas, Jose; Gundle, Roger; Rogers, Mark; Taylor, Adrian; Angus, Brian; Byren, Ivor; Berendt, Anthony R; Warren, Simon; Fitzgerald, Fiona E; Mack, Damien JF; Hopkins, Susan; Folb, Jonathan; Reynolds, Helen E; Moore, Elinor; Marshall, Jocelyn; Jenkins, Neil; Moran, Christopher E; Woodhouse, Andrew F; Stafford, Samantha; Seaton, R Andrew; Vallance, Claire; Hemsley, Carolyn J; Bisnauthsing, Karen; Sandoe, Jonathan AT; Aggarwal, Ila; Ellis, Simon C; Bunn, Deborah J; Sutherland, Rebecca K; Barlow, Gavin; Cooper, Cushla; Geue, Claudia; McMeekin, Nicola; Briggs, Andrew H; Sendi, Parham; Khatamzas, Elham; Wangrangsimakul, Tri; Wong, TH Nicholas; Barrett, Lucinda K; Alvand, Abtin; Old, C Fraser; Bostock, Jennifer; Paul, John; Cooke, Graham; Thwaites, Guy E; Bejon, Philip; Scarborough, Matthew; OVIVA Trial Collaborators
  • Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial. (2019) McMeekin, Nicola; Geue, Claudia; Briggs, Andrew; Rombach, Ines; Li, Ho Kwong; Bejon, Philip; McNally, Martin; Atkins, Bridget L; Ferguson, Jamie; Scarborough, Matthew; OVIVA collaborators
  • Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction. (2018) McMurray, John JV; Trueman, David; Hancock, Elizabeth; Cowie, Martin R; Briggs, Andrew; Taylor, Matthew; Mumby-Croft, Juliet; Woodcock, Fionn; Lacey, Michael; Haroun, Rola; Deschaseaux, Celine
  • Enhancing the Value of the ASCO Value Framework. (2018) Morton, Alec; Bach, Peter B; Briggs, Andrew
  • Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations. (2019) Ouwens, Mario JNM; Mukhopadhyay, Pralay; Zhang, Yiduo; Huang, Min; Latimer, Nicholas; Briggs, Andrew
  • Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study. (2019) Paly, Victoria Federico; Naya, Ian; Gunsoy, Necdet B; Driessen, Maurice T; Risebrough, Nancy; Briggs, Andrew; Ismaila, Afisi S
  • Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts. (2022) Pöhlmann, Johannes; Bergenheim, Klas; Garcia Sanchez, Juan-Jose; Rao, Naveen; Briggs, Andrew; Pollock, Richard F
  • Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial. (2017) Quayyum, Zahidul; Briggs, Andrew; Robles-Zurita, Jose; Oldroyd, Keith; Zeymer, Uwe; Desch, Steffen; Waha, Suzanne de; Thiele, Holger
  • Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. (2020) Robles-Zurita, Jose Antonio; Briggs, Andrew; Rana, Dikshyanta; Quayyum, Zahidul; Oldroyd, Keith G; Zeymer, Uwe; Desch, Steffen; de Waha-Thiele, Suzanne; Thiele, Holger
  • SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer. (2018) Robles-Zurita, José; Boyd, Kathleen A; Briggs, Andrew H; Iveson, Timothy; Kerr, Rachel S; Saunders, Mark P; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Segelov, Eva; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S; Hughes, Rob; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet S; Paul, James
  • Cost-effectiveness analysis of a single-inhaler triple therapy for patients with advanced chronic obstructive pulmonary disease (COPD) using the FULFIL trial: A UK perspective. (2019) Schroeder, Melanie; Shah, Dhvani; Risebrough, Nancy; Martin, Alan; Zhang, Shiyuan; Ndirangu, Kerigo; Briggs, Andrew; Ismaila, Afisi S
  • Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective. (2018) Shah, Dhvani; Driessen, Maurice; Risebrough, Nancy; Baker, Timothy; Naya, Ian; Briggs, Andrew; Ismaila, Afisi S
  • How effective is the Forestry Commission Scotland's woodland improvement programme--'Woods In and Around Towns' (WIAT)--at improving psychological well-being in deprived urban communities? A quasi-experimental study. (2013) Silveirinha de Oliveira, Eva; Aspinall, Peter; Briggs, Andrew; Cummins, Steven; Leyland, Alastair H; Mitchell, Richard; Roe, Jenny; Ward Thompson, Catharine
  • Using Nominal Group Technique to Identify Key Attributes of Oncology Treatments for a Discrete Choice Experiment. (2019) Somers, Camilla; Chimonas, Susan; McIntosh, Emma; Kaltenboeck, Anna; Briggs, Andrew; Bach, Peter
  • A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet. (2018) Stollenwerk, Björn; Iannazzo, Sergio; Akehurst, Ron; Adena, Michael; Briggs, Andrew; Dehmel, Bastian; Parfrey, Patrick; Belozeroff, Vasily
  • A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia. (2016) Städler, Nicolas; Shang, Aijing; Bosch, Francesc; Briggs, Andrew; Goede, Valentin; Berthier, Aurelien; Renaudin, Corinne; Leblond, Veronique
  • Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial. (2017) Sullivan, FM; Farmer, Eoghan; Mair, Frances S; Treweek, Shaun; Kendrick, Denise; Jackson, Cathy; Robertson, Chris; Briggs, Andrew; McCowan, Colin; Bedford, Laura; Young, Ben; Vedhara, Kavita; Gallant, Stephanie; Littleford, Roberta; Robertson, John; Sewell, Herb; Dorward, Alistair; Sarvesvaran, Joseph; Schembri, Stuart
  • Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. (2021) Sullivan, Frank M; Mair, Frances S; Anderson, William; Armory, Pauline; Briggs, Andrew; Chew, Cindy; Dorward, Alistair; Haughney, John; Hogarth, Fiona; Kendrick, Denise; Littleford, Roberta; McConnachie, Alex; McCowan, Colin; McMeekin, Nicola; Patel, Manish; Rauchhaus, Petra; Ritchie, Lewis; Robertson, Chris; Robertson, John; Robles-Zurita, Jose; Sarvesvaran, Joseph; Sewell, Herbert; Sproule, Michael; Taylor, Thomas; Tello, Agnes; Treweek, Shaun; Vedhara, Kavita; Schembri, Stuart; Early Diagnosis of Lung Cancer Scotland (ECLS) Team
  • Enhancing health through access to nature: How effective are interventions in woodlands in deprived urban communities? A quasi-experimental study in Scotland, UK. (2019) Thompson, CW; Elizalde, A; Cummins, S; Leyland, AH; Botha, W; Briggs, A; Tilley, S; de Oliveira, ES; Roe, J; Aspinall, P; Mitchell, R
  • Enhancing Health Through Access to Nature: How Effective are Interventions in Woodlands in Deprived Urban Communities? A Quasi-experimental Study in Scotland, UK. (2019) Thompson, Catharine Ward; Elizalde, Aldo; Cummins, Steven; Leyland, Alastair H; Botha, Willings; Briggs, Andrew; Tilley, Sara; de Oliveira, Eva Silveirinha; Roe, Jenny; Aspinall, Peter; Mitchell, Richard
  • Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia. (2018) Tremblay, Gabriel; Dolph, Mike; Bhor, Menaka; Said, Qayyim; Elliott, Brian; Briggs, Andrew
  • Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons. (2019) Tremblay, Gabriel; Westley, Tracy; Cappelleri, Joseph C; Arondekar, Bhakti; Chan, Geoffrey; Bell, Timothy J; Briggs, Andrew
  • A criterion-based approach to systematic and transparent comparative effectiveness: a case study in psoriatic arthritis. (2019) Tremblay, Gabriel; Westley, Tracy; Forsythe, Anna; Pelletier, Corey; Briggs, Andrew
  • Approaches for Enhanced Extrapolation of Long-Term Survival Outcomes Using Electronic Health Records of Patients With Cancer. (2021) Wang, Xiaoliang; Adamson, Blythe J; Briggs, Andrew; Tan, Katherine; Bargo, Danielle; Ghosh, Shuhag; Baxi, Shrujal; Ramsey, Scott
  • Health impacts of environmental and social interventions designed to increase deprived communities’ access to urban woodlands: a mixed-methods study. (2019) Ward Thompson, Catharine; Silveirinha de Oliveira, Eva; Tilley, Sara; Elizalde, Aldo; Botha, Willings; Briggs, Andrew; Cummins, Steven; Leyland, Alastair H; Roe, Jenny J; Aspinall, Peter; Brookfield, Katherine; Mitchell, Richard
  • Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin. (2020) Wehler, Elizabeth; Lautsch, Dominik; Kowal, Stacey; Davies, Glenn; Briggs, Andrew; Li, Qianyi; Rajpathak, Swapnil; Alsumali, Adnan
  • Cardiac Troponin T and Troponin I in the General Population. (2019) Welsh, Paul; Preiss, David; Hayward, Caroline; Shah, Anoop SV; McAllister, David; Briggs, Andrew; Boachie, Charles; McConnachie, Alex; Padmanabhan, Sandosh; Welsh, Claire; Woodward, Mark; Campbell, Archie; Porteous, David; Mills, Nicholas L; Sattar, Naveed
  • The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought. (2016) Wilkinson, Thomas; Sculpher, Mark J; Claxton, Karl; Revill, Paul; Briggs, Andrew; Cairns, John A; Teerawattananon, Yot; Asfaw, Elias; Lopert, Ruth; Culyer, Anthony J; Walker, Damian G
  • Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial. (2017) Williams, Claire; Lewsey, James D; Briggs, Andrew H; Mackay, Daniel F
  • Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling. (2017) Williams, Claire; Lewsey, James D; Mackay, Daniel F; Briggs, Andrew H
  • Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. (2020) Xin, Yiqiao; Davies, Andrew; Briggs, Andrew; McCombie, Louise; Messow, C Martina; Grieve, Eleanor; Leslie, Wilma S; Taylor, Roy; Lean, Michael EJ
  • From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R. (2021) Xin, Yiqiao; Gray, Ewan; Robles-Zurita, Jose Antonio; Haghpanahan, Houra; Heggie, Robert; Kohli-Lynch, Ciaran; Briggs, Andrew; McAllister, David A; Lawson, Kenny D; Lewsey, Jim
  • Monograph
  • Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT. (2018) Jahoda, Andrew; Hastings, Richard; Hatton, Chris; Cooper, Sally-Ann; McMeekin, Nicola; Dagnan, Dave; Appleton, Kim; Scott, Katie; Fulton, Lauren; Jones, Robert; McConnachie, Alex; Zhang, Rachel; Knight, Rosie; Knowles, Dawn; Williams, Christopher; Briggs, Andy; Melville, Craig